Sulfanilamide Prices

Sulfanilamide Prices June 2023

The price of sulfanilamide in the United States for Q2 2023 reached 26587 USD/MT in June.

The price trend for sulfanilamide in China concluded at 20748 USD/MT, nearing the end of Q2 2023.

The Q2 2023 sulfanilamide price was 28636 USD/MT in Germany.

Sulfanilamide Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Sulfanilamide Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of sulfanilamide pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot prices at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of price trends across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing sulfanilamide price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Sulfanilamide Market Analysis

The global sulfanilamide market size reached US$ 38 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 55 Million, at a projected CAGR of 4.20% during 2023-2032.

• The market is experiencing growth propelled by the increasing incidence of urinary tract infections (UTI), respiratory tract infections, and skin infections necessitating the ongoing use of effective antimicrobial agents like sulfanilamide.
• The market also benefits from the growing awareness about antibiotic treatments in developing regions where healthcare infrastructure is improving, leading to higher adoption rates of these drugs.
• Another significant factor is the broad spectrum of activity that sulfanilamide offers against various gram-positive and gram-negative bacteria, making it a versatile option in both hospital and community settings.
• Besides this, the cost-effectiveness of sulfanilamide, compared to newer antibiotics, makes it an attractive option in resource-limited settings, ensuring its continued demand, and thereby creating a positive outlook for market expansion.
• Moreover, the resurgence of interest in older antibiotics due to the growing problem of antibiotic resistance has led to a renewed focus on sulfanilamide as an alternative treatment option, especially in cases where other antibiotics fail or are contraindicated, which is strengthening the market growth.
• The pharmaceutical industry's efforts in research and development (R&D) to improve the formulations and delivery mechanisms of sulfanilamide, such as developing more effective topical and systemic formulations, are also contributing to the market growth.
• Concurrent with this, the ongoing advancements in pharmaceutical manufacturing processes enhancing the production efficiency and quality of sulfanilamide, driving down costs, and improving accessibility are aiding in market expansion.
• Regulatory approvals and support from government bodies for the continued use and development of sulfanilamide-based medications are providing an impetus to the market growth by encouraging pharmaceutical companies to invest in this segment.
• Additionally, the rise in healthcare expenditure globally, coupled with increasing government initiatives to combat infectious diseases, is boosting the demand for sulfanilamide as part of public health strategies.
• Furthermore, the aging population worldwide, which is more susceptible to infections due to a generally weaker immune system, creates a consistent demand for antimicrobial therapies, including sulfanilamide, bolstering the market expansion.
• Apart from this, the growing trend of self-medication and over-the-counter (OTC) availability of sulfanilamide in various formulations, such as creams, ointments, and oral tablets, makes it readily accessible to consumers, further driving the market growth.

Sulfanilamide News

The report covers the latest developments, updates, and trends impacting the global sulfanilamide market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in sulfanilamide production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that shape the industry landscape.

Latest developments in the sulfanilamide industry:

•  In February 2024, Jazz Pharmaceuticals and Redx Pharma have agreed to acquire global rights to Redx's KRAS inhibitor program, with Jazz receiving an upfront $10 million payment. Redx is eligible for up to $870 million in development, regulatory, and commercial milestone payments from Jazz, with the next milestone being an IND clearance from the U.S. Food and Drug Administration.

Product Description

Sulfanilamide is a synthetic antimicrobial agent that falls under the sulfonamide class of antibiotics. These drugs were the first to be widely utilized as successful chemotherapeutics to treat bacterial infections. Its chemical structure consists of a sulfonamide group (SO₂NH₂) linked to an aniline group (an aromatic amine). Many additional sulfonamide medications, each with a different level of effectiveness and specificity for distinct bacterial illnesses, are based on this basic structure.

Sulfanilamide's mechanism of action involves the inhibition of the bacterial enzyme dihydropteroate synthase, which is crucial in the synthesis of folic acid. Bacteria need folic acid to produce essential nucleic acids (DNA and RNA) and other metabolites. By blocking this pathway, sulfanilamide prevents bacterial growth and multiplication, exerting a bacteriostatic effect.

Sulfanilamide was initially used to treat streptococcal infections, and its success led to the development of many other sulfonamide antibiotics that are used for treating UTIs, some types of meningitis, and certain forms of pneumonia, particularly in patients allergic to penicillin. Additionally, it is used in combination with other drugs to treat specific parasitic infections.

Regional Coverage

The report provides a detailed analysis of the sulfanilamide market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the price trends.

Global Sulfanilamide Price

The report offers a holistic view of the global sulfanilamide pricing trends, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level.

Europe Sulfanilamide Price

European sulfanilamide prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed sulfanilamide price information for a comprehensive list of countries.

North America Sulfanilamide Price

The analysis of sulfanilamide prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific data on sulfanilamide prices within the United States and Canada can also be provided.

Middle East and Africa Sulfanilamide Price

The report explores the sulfanilamide pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on sulfanilamide prices for countries can also be provided.

Asia Pacific Sulfanilamide Price

The sulfanilamide pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This analysis can be further extended to include detailed sulfanilamide prices for a comprehensive list of countries within the region.

Latin America Sulfanilamide Price

The analysis of sulfanilamide prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of sulfanilamide pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting sulfanilamide price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the sulfanilamide industry.